Skip to main content

Hyperplasia

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Apsen Farmaceutica
Apsen FarmaceuticaBrazil - São Paulo
1 program
1
naftopidilPhase 31 trial
Active Trials
NCT01203371Withdrawn0Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Apsen Farmaceuticanaftopidil

Clinical Trials (1)

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Start: Jan 2011Est. completion: Jan 20120
Phase 3Withdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.